Lantheus Presents Data from Two Pivotal Phase 3 Studies of TAUKLARIFY (Florquinitau F 18 Injection) PET Imaging in Early Alzheimer’s Disease
Results presented at CTAD 2026 demonstrated high sensitivity, specificity and inter-reader agreement across two pivotal Phase 3 studies utilizing a novel prospectively defined clinical radiological reference standard Results presented at CTAD 2026 demonstrated high sensitivity, specificity and inter-reader agreement across two pivotal Phase 3 studies utilizing a novel prospectively defined clinical radiological reference standard